Andy Altahawi has recently made his mark on the world stage with the highly anticipated IPO of his company on the New York Stock Exchange. This achievement has sent shockwaves through the fool biotech companies financial market, and many are hailing Altahawi as a force to be reckoned with. His company, which specializes in innovative technologies,